Yoda Pharmaceuticals Inc.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

N/A

Website

yodapharma.com

Country

Cayman Islands

Exchange

Taipei Exchange

Yoda Pharmaceuticals Inc., an AI-driven company focuses on development of drugs targeting central nervous system disorders. The company's flagship drug, YA-101 is in Phase 2 clinical trial for the treatment of multiple system atrophy.

It is also involved in the development pipeline includes drugs in the field of neurological and psychiatric disorders and cerebrovascular diseases, targeting conditions, such as schizophrenia, Alzheimer's disease, Parkinsons disease, Autism, ischemic stroke, and traumatic brain injury. Yoda Pharmaceuticals Inc. was incorporated in 2019 and is based in Grand Cayman, the Cayman Islands.

Key Stats

52-Week Range

NT$32.90NT$77.60

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-5.14

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.